1/2

Export Ready

Sofosbuvir and daclatasvir tablets I.P

Name: Sofosbuvir and daclatasvir tablets I.P
SKU: 8484111
Availability: InStoreOnly

Sold by ayursatva pharma llp · Raigad, Maharashtra, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Blister packs of 10 or 30 tablets

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for ayursatva pharma llp.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Raigad Dispatch on request Verified seller

ayursatva pharma llp

Verified seller · Raigad, Maharashtra, India

Registered address: RAIGAD, India.

View profile All products

Established

Not shared

Employees

–

GST

27ACGFA6465R1ZM

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Not shared

Turnover

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

Sofosbuvir and daclatasvir is used in the treatment of chronic hepatitis C virus (HCV) infection .

Product Description

Sofosbuvir and daclatasvir is used in the treatment of chronic hepatitis C virus (HCV) infection .

Description provided by ayursatva pharma llp.

Specifications

Sofosbuvir Content	400 mg per tablet
Daclatasvir Content	60 mg per tablet
Tablet Shape	Film-coated, oval-shaped
Packaging	Blister packs of 10 or 30 tablets
Shelf Life	24 months from manufacturing date
Storage Temperature	15°C to 30°C
Regulatory Standard	I.P - Indian Pharmacopoeia

Use cases

Category	Pharmaceuticals > Antiviral Drugs > Hepatitis C Treatments
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Blister packs of 10 or 30 tablets
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Sofosbuvir and daclatasvir tablets I.P. Answers compiled from verified sellers' commercial terms and platform data.

Q: What specific stages of HCV replication does Sofosbuvir and daclatasvir target?

A: Sofosbuvir inhibits the HCV RNA-dependent RNA polymerase (NS5B), while daclatasvir targets the NS5A protein, thereby preventing viral replication and assembly.

Q: Is this combination effective against all genotypes of the hepatitis C virus?

A: Yes, Sofosbuvir and daclatasvir tablets have proven efficacy across multiple HCV genotypes, making them suitable for broad-spectrum antiviral therapy.

Q: What packaging options are available for industrial procurement?

A: These tablets are available in blister packs containing 10 or 30 tablets per pack, suitable for bulk medical use.

Q: What regulatory standards does this product comply with?

A: The product conforms to Indian Pharmacopoeia (I.P) standards, ensuring quality, purity, and therapeutic consistency.

Q: What are the recommended storage conditions for these tablets?

A: They should be stored in a cool, dry place with temperatures between 15°C and 30°C, away from direct light and moisture.

Question not answered? Ask sellers directly — typical response within 4 hours.